First catalog of spiders of Egypt (Araneae)

Posted by
  First catalog of spiders of Egypt (Araneae) Abstract This study provides a comprehensive catalog of the spider fauna of Egypt, comprising 389 species assigned to 197 genera and 40 families. For each species, all published locality records are compiled and accompanied by complete bibliographic references. The dataset has been carefully reviewed and critically evaluated in light of the most recent taxonomic and faunistic information. Among the recorded species, 55 (14.13%) are currently known only from Egypt and are thus considered endemic. Based on the World Spider Catalog (2026), 28 species are treated as nomina dubia, 23 species lack confirmed records from Egypt, which is not correct, 10 have to be omitted from the Egyptian list and 8 are species inquirenda. Despite the relatively high number of documented species, the Egyptian araneofauna remains insufficiently explored. Given the country’s ecological diversity and biogeographical position, further research is expected to signi...

Venom variation and the future of antivenom design: integrating population venomics, evolutionary toxinology, and precision therapeutics

Posted by

 


Venom variation and the future of antivenom design: integrating population venomics, evolutionary toxinology, and precision therapeutics

Abstract

Snakebite envenoming remains a neglected tropical disease that disproportionately affects rural populations in the tropical regions, where access to timely and effective treatment is often limited. Conventional antivenoms, produced by immunizing animals with pooled venoms, have demonstrated clinical benefit but may show variable performance against the complex and geographically heterogeneous composition of snake venoms. Advances in proteomics, transcriptomics, and genomics have revealed substantial intra- and interspecies venom variation with potential implications for antivenom design and evaluation. This review synthesizes current knowledge on the molecular, ecological, and evolutionary drivers of venom diversity and discusses how these insights may inform the development of more regionally informed and evidence-based therapeutic strategies. Particular attention is given to toxin-resolved antivenomics, monoclonal antibody research, recombinant platforms, and emerging computational tools for antigen prioritization. The potential role of rapid diagnostics and immunoinformatics in supporting clinical decision-making is also considered. Overall, the review highlights how population-level venom data and translational research may contribute to incremental improvements in antivenom design, while acknowledging the regulatory, economic, and implementation challenges involved.
Dingwoke, E. J. (2026). Venom variation and the future of antivenom design: Integrating population venomics, evolutionary toxinology, and precision therapeutics. Toxicon: X, 100246. https://doi.org/10.1016/j.toxcx.2026.100246